• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagn Interv Imaging . COVID-19: A qualitative chest CT model to identify severe form of the disease

tetano

Editor, Senior Moderator
Diagn Interv Imaging


. 2020 Dec 17;S2211-5684(20)30306-5.
doi: 10.1016/j.diii.2020.12.002. Online ahead of print.
COVID-19: A qualitative chest CT model to identify severe form of the disease


Antoine Devie[SUP] 1 [/SUP], Lukshe Kanagaratnam[SUP] 2 [/SUP], Jeanne-Marie Perotin[SUP] 3 [/SUP], Damien Jolly[SUP] 2 [/SUP], Jean-No?l Ravey[SUP] 4 [/SUP], Manel Djelouah[SUP] 5 [/SUP], Christine Hoeffel[SUP] 6 [/SUP]



Affiliations

Abstract

Purpose: The purpose of this study was to identify clinical and chest computed tomography (CT) features associated with a severe form of coronavirus disease 2019 (COVID-19) and to propose a quick and easy to use model to identify patients at risk of a severe form.
Materials and methods: A total of 158 patients with biologically confirmed COVID-19 who underwent a chest CT after the onset of the symptoms were included. There were 84 men and 74 women with a mean age of 68?14 (SD) years (range: 24-96years). There were 100 non-severe and 58 severe cases. Their clinical data were recorded and the first chest CT examination was reviewed using a computerized standardized report. Univariate and multivariate analyses were performed in order to identify the risk factors associated with disease severity. Two models were built: one was based only on qualitative CT features and the other one included a semi-quantitative total CT score to replace the variable representing the extent of the disease. Areas under the ROC curves (AUC) of the two models were compared with DeLong's method.
Results: Central involvement of lung parenchyma (P<0.001), area of consolidation (P<0.008), air bronchogram sign (P<0.001), bronchiectasis (P<0.001), traction bronchiectasis (P<0.011), pleural effusion (P<0.026), large involvement of either one of the upper lobes or of the middle lobe (P<0.001) and total CT score≥15 (P<0.001) were more often observed in the severe group than in the non-severe group. No significant differences were found between the qualitative model (large involvement of either upper lobes or middle lobe [odd ratio (OR)=2.473], central involvement [OR=2.760], pleural effusion [OR=2.699]) and the semi-quantitative model (total CT score≥15 [OR=3.342], central involvement [OR=2.344], pleural effusion [OR=2.754]) with AUC of 0.722 (95% CI: 0.638-0.806) vs. 0.739 (95% CI: 0.656-0.823), respectively (P=0.209).
Conclusion: We have developed a new qualitative chest CT-based multivariate model that provides independent risk factors associated with severe form of COVID-19.

Keywords: COVID-19; Risk factors; Severe acute respiratory syndrome coronavirus 2; Severity of illness index; Tomography; X-ray computed (CT).
 
Back
Top Bottom